Tyra Biosciences, Inc. · NASDAQ:TYRA
Commodore Capital LP reported a 6.30% stake in Tyra Biosciences, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Commodore Capital LP reported a 6.30% stake in Tyra Biosciences, Inc., 3,375,000 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 6.30%
- Shares
- 3,375,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 6.30% | 3,375,000 |
| Commodore Capital Master LP | 6.30% | 3,375,000 |
| Robert Egen Atkinson | 6.30% | 3,375,000 |
| Michael Kramarz | 6.30% | 3,375,000 |
Source
Related
- Tyra Biosciences, Inc.
- Commodore Capital LP
- Tyra Biosciences, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · May 15, 2026
- Schedule 13G · Commodore Capital LP · May 14, 2025
- Schedule 13G · Bvf Partners L P · Sep 21, 2026
- Form 4 · Harris Todd · Sep 17, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026